Literature DB >> 7085128

Studies of human natural killer cells. I. In vivo parameters affecting normal cytotoxic function.

H F Pross, M G Baines.   

Abstract

The results of natural killer cell (NK) studies on 539 normal healthy donors tested from once to 213 times over a seven-year time span have been presented. NK activity did not vary with donor blood group, Rh type or (in a small sample) HLA type. There was a slight but significant increase in NK activity from birth to adulthood, and between males an females. The male/female difference was present at birth and persisted through adulthood. The relative NK activity of individual donors tested repeatedly over many years was remarkably consistent in spite of variability in the absolute cytotoxicity observed. The expression of NK data in terms of relative NK was found to be superior to other methods, and the values obtained were found to be independent of the NK-sensitive target cell used. Although age and sex differences in NK activity are slight, their existence should be considered when studies of NK activity in patients are analysed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7085128     DOI: 10.1002/ijc.2910290404

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood.

Authors:  G J Ligthart; H R Schuit; W Hijmans
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

2.  Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide.

Authors:  J Berry; B J Green; D S Matheson
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 3.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

Review 4.  Manipulation of host resistance in cancer therapy.

Authors:  R W Baldwin
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Low doses of interferon alpha result in more effective clinical natural killer cell activation.

Authors:  B S Edwards; J A Merritt; R C Fuhlbrigge; E C Borden
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

6.  Variation in natural killer activity in peripheral blood during the menstrual cycle.

Authors:  A N Sulke; D B Jones; P J Wood
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23

7.  Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancer.

Authors:  I R Mackay; M D Goodyear; C Riglar; J Penschow
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Motivational syndromes associated with natural killer cell activity.

Authors:  J B Jemmott; C Hellman; D C McClelland; S E Locke; L Kraus; R M Williams; C R Valeri
Journal:  J Behav Med       Date:  1990-02

9.  Natural cell-mediated cytotoxicity in normal human peripheral blood lymphocytes and its in vitro boosting with BCG.

Authors:  R Mandeville; F M Sombo; N Rocheleau
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Factors affecting the spontaneous cell-mediated cytotoxicity of intestinal mononuclear cells.

Authors:  P R Gibson; A Hermanowicz; D P Jewell
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.